Aztreonam
- Generic Name
- Aztreonam
- Brand Names
- Azactam, Cayston
- Drug Type
- Small Molecule
- Chemical Formula
- C13H17N5O8S2
- CAS Number
- 78110-38-0
- Unique Ingredient Identifier
- G2B4VE5GH8
- Background
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
- Indication
For the treatment of the following infections caused by susceptible gram-negative microorganisms: urinary tract infections, lower respiratory tract infections, septicemia, skin and skin-structure infections, intra-abdominal infections, and gynecologic infections.
- Associated Conditions
- Bone and Joint Infections, Cystic Fibrosis (CF), Febrile Neutropenia, Gynecological Infection, Intraabdominal Infections, Lower Respiratory Tract Infection (LRTI), Osteomyelitis, Septic Arthritis, Septicemia, Skin Infections, Urinary Tract Infection, Uncomplicated Gonorrhea
Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa
Phase 3
Completed
- Conditions
- Cystic Fibrosis
- Interventions
- First Posted Date
- 2008-09-23
- Last Posted Date
- 2011-07-04
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 274
- Registration Number
- NCT00757237
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
Phase 2
Completed
- Conditions
- Bacterial Infection
- Interventions
- First Posted Date
- 2008-03-11
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 150
- Registration Number
- NCT00633152
- Locations
- 🇺🇸
Investigational Site, Toledo, Ohio, United States
Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection
- Conditions
- Cystic FibrosisPseudomonas Aeruginosa Airway Infection
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2011-08-02
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00499720
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath